News | April 07, 2024
Bayer and Dr. Reddy's sign marketing and distribution agreement for second brand of Vericiguat in India
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Highly effective preservation solutions ensuring the safety and protection of personal care products
The observations are procedural in nature and will be responded to within the stipulated time
A game changing solution for the pharmaceutical industry
_256_384.jpg)
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus
Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
